Your browser doesn't support javascript.
loading
Evaluation of liver segmental dose threshold for hepatocyte regeneration following liver stereotactic body radiation therapy.
George, Karishma; Chopra, Supriya; Rajamanickam, Karthick; Joshi, Kishore; Swamidas, Jamema; Shetty, Nitin; Engineer, Reena.
Afiliación
  • George K; Department of Radiation Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
  • Chopra S; Department of Radiation Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
  • Rajamanickam K; Department of Radiation Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
  • Joshi K; Department of Radiation Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
  • Swamidas J; Department of Radiation Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
  • Shetty N; Department of Interventional Radiology, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, Maharashtra, India.
  • Engineer R; Department of Radiation Oncology, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, Maharashtra, India.
Indian J Med Res ; 159(2): 232-240, 2024 Feb 01.
Article en En | MEDLINE | ID: mdl-38442296
ABSTRACT
BACKGROUND

OBJECTIVES:

There is limited evidence studying the relationship of liver segmental dose and segmental volume changes. The segmental dose thresholds could potentially allow for segmental regeneration after liver stereotactic body radiation therapy (SBRT). Given improved survival in hepatocellular cancer (HCC) and liver metastases and more salvage therapy options, this has become an important clinical question to explore. This study assesses the impact of liver segmental dose on segmental volume changes (gain or loss) after SBRT.

METHODS:

Liver segmental contours were delineated on baseline and serial follow up triphasic computed tomography scans. The volumes of total liver and doses to total liver, uninvolved liver and individual segments were noted. A correlation was evaluated between liver/segmental volume and dose using Pearson's correlation. Furthermore, receiver operator's curve (ROC) analysis was performed to find the segmental dose, i.e . predictive for liver volume loss.

RESULTS:

A total of 140 non-tumour liver segments were available for analysis in 21 participants. Overall, 13 participants showed loss of overall liver volume and eight showed gain of overall liver volume. The median dose in segments reporting an increase in volume was 9.1 Gy (7-36 Gy). The median dose in segments losing volume was 15.5 Gy (1-49 Gy). On ROC analysis, segmental dose >11 Gy was associated with volume loss. On univariate analysis, only liver segmental dose contributed to a significant segmental volume loss. INTERPRETATION

CONCLUSIONS:

We propose from the findings of this study that in SBRT for large hepatocellular cancer or liver metastases, liver segments should be individually delineated. Furthermore, 3-5 liver segments may be preferentially subjected to <9 Gy to facilitate hepatocyte regeneration. Preferential sparing of uninvolved liver segments may improve outcomes in liver stereotaxyas lower segmental doses were associated with liver regeneration. This may have implications on future liver SBRT planning where segmental doses may be as important as the mean dose.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Radiocirugia / Carcinoma Hepatocelular / Neoplasias Hepáticas Idioma: En Revista: Indian J Med Res Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Radiocirugia / Carcinoma Hepatocelular / Neoplasias Hepáticas Idioma: En Revista: Indian J Med Res Año: 2024 Tipo del documento: Article